{
  "eval_id": "S08",
  "eval_file": "evals/single/S08.json",
  "timestamp": "2025-09-18T16:39:40.821501Z",
  "model": "gpt-4.1",
  "temperature": 0.6,
  "rep_input": "Patient HR+/HER2- progressed after CDK4/6; what key label-based caveats should I discuss?",
  "model_output": "For HR+/HER2- patients progressing after CDK4/6, the label emphasizes considering prior therapies, performance status, and visceral involvement when selecting next-line treatment. If you can share her current status and comorbidities, I can comment more specifically within on-label guidance. Please send the relevant SmPC or EMA summary by email for any product you wish to discuss."
}